<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is a pleiotropic <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorder</z:e> with major features in cardiovascular, ocular and skeletal systems, associated with large clinical variability </plain></SENT>
<SENT sid="1" pm="."><plain>Numerous studies reveal an involvement of TGF-β signaling </plain></SENT>
<SENT sid="2" pm="."><plain>However, the contribution of tissue <z:mp ids='MP_0001845'>inflammation</z:mp> is not addressed so far </plain></SENT>
<SENT sid="3" pm="."><plain>METHODOLOGY/PRINCIPAL FINDINGS: Here we showed that both TGF-β and <z:mp ids='MP_0001845'>inflammation</z:mp> are up-regulated in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We analyzed transcriptome-wide gene expression in 55 MFS patients using Affymetrix Human Exon 1.0 ST Array and levels of TGF-β and various cytokines in their plasma </plain></SENT>
<SENT sid="5" pm="."><plain>Within our <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> population, increased plasma levels of TGF-β were found especially in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> patients with <z:hpo ids='HP_0002616'>aortic root dilatation</z:hpo> (124 pg/ml), when compared to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> patients with <z:mpath ids='MPATH_458'>normal</z:mpath> aorta (10 pg/ml; p = 8×10(-6), 95% CI: 70-159 pg/ml) </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, our microarray data show that increased expression of inflammatory genes was associated with major clinical features within the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> patients group; namely severity of the <z:hpo ids='HP_0002616'>aortic root dilatation</z:hpo> (HLA-DRB1 and HLA-DRB5 genes; r = 0.56 for both; False Discovery Rate(FDR) = 0%), ocular <z:hpo ids='HP_0001083'>lens dislocation</z:hpo> (RAET1L, CCL19 and HLA-DQB2; Fold Change (FC) = 1.8; 1.4; 1.5, FDR = 0%) and specific skeletal features (HLA-DRB1, HLA-DRB5, GZMK; FC = 8.8, 7.1, 1.3; FDR = 0%) </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with progressive <z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic disease</z:e> had higher levels of Macrophage Colony Stimulating Factor (M-CSF) in blood </plain></SENT>
<SENT sid="8" pm="."><plain>When comparing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> aortic root vessel wall with non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> aortic root, increased numbers of CD4+ T-cells were found in the media (p = 0.02) and increased number of CD8+ T-cells (p = 0.003) in the adventitia of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> patients </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION/SIGNIFICANCE: In conclusion, our results imply a modifying role of <z:mp ids='MP_0001845'>inflammation</z:mp> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> might be a novel therapeutic target in these patients </plain></SENT>
</text></document>